StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) Wins Reversal of First St. Louis Talc-Cancer Verdict - Bloomberg
October 17, 2017 12:00 PM
Johnson & Johnson ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Litigation
Trader Talk
Next Articles
Johnson & Johnson (JNJ) Declares $0.84 Quarterly Dividend; 2.4% Yield
October 19, 2017 6:55 AM
Johnson & Johnson (JNJ) PT Raised to $142 at Stifel on 3Q Earnings Report; 'Pharma Carries the Day, Hurricane Headwinds Encouragingly Modest
October 17, 2017 5:16 PM